SCINAI IMMUNOTHERAPEUTICS LTD. Sale Leaseback Transaction, Gross Proceeds, Financing Activities
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Sale Leaseback Transaction, Gross Proceeds, Financing Activities of $8.00 million for the 1-month period ending 2022-12-20, per its 6-K/A filed 2023-08-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:SaleLeasebackTransactionGrossProceedsFinancingActivities · last filed 2023-08-18
- 2022-12-20: Sale Leaseback Transaction, Gross Proceeds, Financing Activities 1 month $8.00M; Sale Leaseback Transaction, Gross Proceeds, Financing Activities 1 month as first filed $8.00B.
- 2021-12-27: Sale Leaseback Transaction, Gross Proceeds, Financing Activities 1 month $9.78M.
| Period end | Sale Leaseback Transaction, Gross Proceeds, Financing Activities 1 month | Sale Leaseback Transaction, Gross Proceeds, Financing Activities 1 month as first filed |
|---|---|---|
| 2022-12-20 | $8.00M 6-K/A · filed 2023-08-18 | $8.00B 10-K · filed 2023-04-17 |
| 2021-12-27 | $9.78M 10-K · filed 2023-04-17 |